Health & Medicine
-
Reliance gains edge in cancer detection with new liquid biopsy patent
MUMBAI, July 7 — An Indian patent for a blood-based early cancer detection platform using cell-free DNA analysis has been granted to…
-
Strengthening Alberta’s Clinical Trial Infrastructure with New Funding
EDMONTON, July 7 — A significant investment in clinical trials is set to transform cancer care in Alberta, with the Alberta Cancer…
-
Alberta Cancer Foundation Commits $35 Million to Cancer Clinical Trials
EDMONTON, July 7 — Wendy Beauchesne has spent the last six years at the helm of the Alberta Cancer Foundation, and on…
-
Next-Gen CAR-T Therapies, Including CRISPR Versions, in Trials
ISLAMABAD, July 7 — The next generation of CAR-T cell therapies is moving closer to the clinic, promising to solve some of…
-
BEYOND-PSA Study Invites 10,000 London Men to Test New Prostate Blood Test
LONDON, July 7 — A charity dedicated to tackling the most common cancer in men is hoping a new fundraising drive will…
-
Campbell Roy walks 540 miles for prostate cancer research
LHANBRYDE, Scotland, July 7 — A 71-year-old man from Moray is walking 540 miles across Scotland to raise funds for prostate cancer…
-
Campbell Roy to Walk 537 Miles Across Scotland for Prostate Cancer Research
LONDON, July 7 — When Sir Chris Hoy, a six-time Olympic gold medalist and 11-time world champion cyclist, retired from competitive cycling,…
-
Alberta Cancer Foundation Invests $35M in 10-Year Trial Strategy
EDMONTON, July 7 — The Alberta Cancer Foundation has placed a strategic bet on the future of oncology, announcing a $35 million…
-
Owerko Centre Among Sites Sharing Alberta Cancer Foundation’s $35M Trials Fund
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
FDA Approves Breyanzi CAR-T for Relapsed CLL After Trial Showing 20% Complete Response
NEW YORK, July 7 — A landmark clinical trial has led to the first-ever approval of a CAR-T cell therapy for patients…
-
Strand Life Sciences Wins Indian Patent for Blood-Based Early Cancer Detection Test
BANGALORE, July 7 — A new patented technology from Strand Life Sciences is changing how doctors look for cancer in its earliest,…
-
Emily Whitehead, First Child Given CAR T Therapy, Cancer-Free More Than Nine Years Later
PHILLIPSBURG, N.J., July 7 — In the long, often heartbreaking history of childhood cancer research, there are a handful of moments that…
-
Reliance Unit Strand Life Sciences Wins Indian Patent for Blood-Based Cancer Detection
BENGALURU, July 7 — Strand Life Sciences, the genomic diagnostics subsidiary of Reliance Industries Limited, has secured an Indian patent for an…
-
Global Dietary Database Launched to Assess Food’s Health, Environmental, and Economic Impacts
LONDON, July 4 — A new global dietary database designed to support health, environmental and economic impact assessments has been developed by…
-
Oncologist Explains Why More Indians in Their 30s Are Being Diagnosed With Cancer
NEW DELHI, July 5 — For decades, cancer carried an image of being an illness that arrived late in life. That image…
-
Melbourne Banker’s Faint Chest Ache Turned Out to Be a Rare, Aggressive Cancer
MELBOURNE, July 5 — A young finance professional who dismissed a strange chest ache as a training strain was later diagnosed with…
-
Immunotherapy’s high cost creates divide in cancer care
NEW YORK, July 5 — The figure that matters: $100,000 to $200,000 per patient per year. That is the annual price tag…
-
Immunotherapy Revolution: New Cancer Treatments Transform Patient
PHILADELPHIA, July 5 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope over the last…
-
UK Phase 2 Trial Opens to Test CY-101 in Rare Adrenal Cancer
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
Personalized Vaccine Plus Immunotherapy Shows Promise in Advanced Head and Neck Cancer
NEW YORK, July 5, 2026 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope. The…
-
Ancient Immune Protein Made Inside Tumors Boosts Cancer Immunotherapy in Nagoya Study
“You can’t just rip out a receptor that does useful work everywhere in the body,” said Erick M. Carreira, co-leader of the…
-
ETH Zurich Builds Light-Controlled Switch That Wakes Dormant Lung Cancer Cells in the Lab
One number sits at the center of this new cancer research: the glucocorticoid receptor. It is a single protein. It is the…
-
Checkpoint inhibitors in melanoma and bladder cancer: approvals, combination results and costs
LONDON, July 5 — Bristol Myers Squibb, the New York-based pharmaceutical company, developed two of the foundational checkpoint inhibitors that reshaped oncology:…
-
US Cancer Survival Rose From 49% to 69% Since 1975, but Gains Are Uneven
NEW YORK, July 5 — For families facing a cancer diagnosis, the language of treatment can feel like a foreign country. Words…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992